Reference priceEUR €4.84Original source price: INR 440.00. Converted estimates are available by currency selection.
| Brand | Lupkynis |
|---|---|
| Manufacturer | Otsuka Pharma GmbH |
| Prescription required | Yes |
Lupkynis 7.9mg Weichkapseln,1 x 180St(voclosporin)
voclosporin
Description
Lupkynis 7.9mg Weichkapseln,1 x 180St(voclosporin) is a medicine catalog record in the MediPriceHub database. Active ingredient: voclosporin. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Otsuka Pharma GmbH. Therapeutic category: Medicine Library > Dermatology Medicines > Lupus medication. Pack information: 7.9, 180. Origin country or market: Germany. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
LUPKYNIS is indicated in combination with a background immunosuppressive therapy regimen [see Clinical Studies ] for the treatment of adult patients with active lupus nephritis (LN). Limitations of Use: Safety and efficacy of LUPKYNIS have not been established in combination with cyclophosphamide. Use of LUPKYNIS is not recommended in this situation.How to Use
Use voclosporin under the supervision of a qualified healthcare professional. Use it only according to the approved label and the instructions of a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: voclosporin. Pack size: 7.9, 180. Pack unit: bottle. Manufacturer: Otsuka Pharma GmbH. Origin country: Germany. Source category: Medicine Library > Dermatology Medicines > Lupus medication. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Possible adverse effects vary by active ingredient, dose, route, treatment duration, and patient condition. Common issues may include gastrointestinal symptoms, headache, dizziness, fatigue, rash, allergic reactions, or abnormal laboratory tests. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.